Ceftaroline fosamil laden allograft: A new modality in reducing infection?

Ceftaroline fosamil laden allograft: A new modality in reducing infection?

Show other versions (1)

Purpose: Allograft infection remains the greatest challenge in orthopaedic reconstructive surgery especially methicillin-resistant Staphylococcus aureus (MRSA). This risk can be minimized with the use of antibiotic laden allograft (ALA) via iontophoresis. Ceftaroline fosamil (CF) is an advanced-gene...

Full description

Bibliographic Details
Main Authors:	Vivek Ajit Singh, Lim Han Sim, Amber Haseeb, Cindy Teh Shuan Ju
Format:	Article
Language:	English
Published:	SAGE Publishing 2018-10-01
Series:	Journal of Orthopaedic Surgery
Online Access:	https://doi.org/10.1177/2309499018806671

Similar Items

Ceftaroline fosamil laden allograft: A new modality in reducing infection?
by: Singh, Vivek Ajit, et al.
Published: (2018)

Addition of ceftaroline fosamil or vancomycin to PMMA: An in vitro comparison of biomechanical properties and anti-MRSA efficacy
by: Amber Haseeb, et al.
Published: (2019-05-01)

Use of Ceftaroline Fosamil in Osteomyelitis: CAPTURE Study Experience
by: Leonard B. Johnson, et al.
Published: (2019-02-01)

Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in the intensive care unit
by: Maggiore C, et al.
Published: (2015-04-01)

Efficacy and effectiveness of Ceftaroline Fosamil in patients with pneumonia: a systematic review and meta-analysis
by: Giovanni Sotgiu, et al.
Published: (2018-10-01)

Systematic review of ceftaroline fosamil in the management of patients with methicillin-resistant Staphylococcus aureus pneumonia
by: Antoní Torres, et al.
Published: (2023-10-01)

Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study
by: Samia Arshad, et al.
Published: (2017-04-01)

Development and validation of a new analytical method based on UV-visible spectroscopy for quantification of ceftaroline fosamil in powder for injection
by: Lilian F. Machioli, et al.
Published: (2023-07-01)

Ceftaroline fosamil: development a rapid HPLC method indicating stability and bioassay for determination in pharmaceutical formulation, stability and cytotoxicity studies
by: Idamir José Mascarello Junior, et al.
Published: (2021-12-01)

Ceftaroline fosamil: development a rapid HPLC method indicating stability and bioassay for determination in pharmaceutical formulation, stability and cytotoxicity studies
by: Idamir José Mascarello Junior, et al.
Published: (2021-12-01)

Ceftaroline fosamil: development a rapid HPLC method indicating stability and bioassay for determination in pharmaceutical formulation, stability and cytotoxicity studies
by: Idamir José Mascarello Junior, et al.
Published: (2021-12-01)

Ceftaroline fosamil: development a rapid HPLC method indicating stability and bioassay for determination in pharmaceutical formulation, stability and cytotoxicity studies
by: Idamir José Mascarello Junior, et al.
Published: (2021-12-01)

Ceftaroline fosamil: development a rapid HPLC method indicating stability and bioassay for determination in pharmaceutical formulation, stability and cytotoxicity studies
by: Idamir José Mascarello Junior, et al.
Published: (2021-12-01)

Treatment outcomes of secondary bacteraemia in patients treated with ceftaroline fosamil: pooled results from six phase III clinical trials
by: Matthew Dryden, et al.
Published: (2022-03-01)

Ceftaroline Fosamil for the Empiric Treatment of Hospitalized Adults with cSSTI: An Economic Analysis from the Perspective of the Spanish National Health System
by: Torres A, et al.
Published: (2022-03-01)

Clinico-Economic Effectiveness of Ceftaroline Fosamil for the Treatment of Hospitalised Patients with Pneumococcal Community-Acquired Pneumonia from a Societal Perspective
by: Belkova Yu.А., et al.
Published: (2015-02-01)

The use of extrapolation based on modeling and simulation to support high‐dose regimens of ceftaroline fosamil in pediatric patients with complicated skin and soft‐tissue infections
by: Phylinda L.S. Chan, et al.
Published: (2021-06-01)

Efficacy and Safety of Ceftaroline Fosamil in Hospitalized Patients with Community-Acquired Pneumonia in China: Subset Analysis of an International Phase 3 Randomized Controlled Trial
by: Zhuo C, et al.
Published: (2022-02-01)

Hand-mixed vancomycin versus commercial tobramycin cement revisited: A study on mechanical and antibacterial properties
by: Singh, Vivek Ajit, et al.
Published: (2019)

JectOS® versus PMMA vancomycin-loaded cement: The biomechanical and antimicrobial properties
by: Singh, Vivek Ajit, et al.
Published: (2019)

Open-Label Randomized Trial of Early Clinical Outcomes of Ceftaroline Fosamil Versus Vancomycin for the Treatment of Acute Bacterial Skin and Skin Structure Infections at Risk of Methicillin-Resistant Staphylococcus aureus
by: Kimberly C. Claeys, et al.
Published: (2019-03-01)

JectOS® versus PMMA vancomycin-loaded cement: The biomechanical and antimicrobial properties
by: Vivek Ajit Singh, et al.
Published: (2019-01-01)

Resistance to ceftaroline - 2018 review
by: Rafał Ślusarczyk, et al.
Published: (2018-07-01)

In Silico Study of Ceftaroline’s Molecular Properties
by: Elso Manuel Cruz Cruz, et al.
Published: (2011-03-01)

In Silico Study of Ceftaroline’s Molecular Properties
by: Elso Manuel Cruz Cruz, et al.
Published: (2011-03-01)

Ceftaroline-related acute eosinophilic pneumonia
by: Zaw Min, et al.
Published: (2021-01-01)

Characterizing the role of porin mutations in susceptibility of beta lactamase producing Klebsiella pneumoniae isolates to ceftaroline and ceftaroline-avibactam
by: Ali Khalid, et al.
Published: (2020-04-01)

Comparative pharmacoeconomic analysis of ceffaroline fosamil in the treatment of complicated skin and soft tissues infections
by: S. K. Zyryanov, et al.
Published: (2018-05-01)

Reduced model for particle laden flow
by: Zhou, Junjie, 1979-
Published: (2005)

Susceptibility of Clinical Isolates of Staphylococcus aureus to Ceftaroline
by: Harsha Sreedharan, et al.
Published: (2021-01-01)

IN VITRO SUSCEPTIBILITY OF MRSA CLINICAL ISOLATES TO CEFTAROLINE
by: Muhammad Aurangzeb, et al.
Published: (2018-04-01)

Efficacy and safety of ceftaroline: systematic review and meta-analysis
by: Maria T. Rosanova, et al.
Published: (2019-01-01)

Cell-Laden Composite Hydrogel Bioinks with Human Bone Allograft Particles to Enhance Stem Cell Osteogenesis
by: Hadis Gharacheh, et al.
Published: (2022-09-01)

Cannulated Screw Fixation For Femoral Neck Fractures : A 5-year Experience In A Single Institution
by: Khoo CCH, et al.
Published: (2014-07-01)

Cryopreservation versus fresh frozen meniscal allograft: A biomechanical comparative analysis
by: Shukur Ahmad, et al.
Published: (2017-08-01)

Daptomycin plus ceftaroline salvage therapy for persistent Staphylococcus epidermidis bacteremia
by: Hayden Zhang, et al.
Published: (2024-02-01)

Evaluation of the synergistic effect of ceftaroline against methicillin-resistant Staphylococcus aureus
by: Cheng-En Tsai, et al.
Published: (2022-09-01)

Clinical evaluation of the role of ceftaroline in the management of community acquired bacterial pneumonia
by: Maselli DJ, et al.
Published: (2012-02-01)

Effects of Subinhibitory Concentrations of Ceftaroline on Methicillin-Resistant Staphylococcus aureus (MRSA) Biofilms.
by: María Lázaro-Díez, et al.
Published: (2016-01-01)

Ceftaroline versus vancomycin for treatment of acute pulmonary exacerbations of cystic fibrosis in adults
by: Marc D. Esquivel, et al.
Published: (2022-03-01)